PMV Pharmaceuticals, Inc. — Investor Relations & Filings

PMV Pharmaceuticals, Inc. is a clinical-stage precision oncology company focused on the discovery and development of small molecule, tumor-agnostic therapies. The company's research centers on the p53 tumor suppressor protein, which is mutated in approximately half of all human cancers. PMV Pharmaceuticals develops first-in-class drug candidates, referred to as p53 regulators, designed to selectively target these mutations. The company's therapeutic approach aims to structurally correct the mutated p53 protein, thereby restoring its normal, wild-type tumor-suppressing function to treat various forms of cancer.